Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Recombinant human follicle stimulating hormone alpha 75iu powder and solvent for injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 150iu powder and solvent for injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 37.5iu powder and solvent for injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Product containing follitropin alfa and lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Corifollitropin alfa |
Is a |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 37.5iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Follitropin alfa (substance) |
Inferred relationship |
Some |
|
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa 300 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa 300 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing follitropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing only follitropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa 600 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |
Follitropin alfa 600 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Follitropin alfa (substance) |
Inferred relationship |
Some |
1 |